← Back to Clinical Trials
Recruiting NCT06752252

NCT06752252 Ultrasound Guided Paravertebral Block Versus Erector Spinae Block for Postoperative Analgesia After Inguinal Hernia Repair in Pediatric Patients

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06752252
Status Recruiting
Phase
Sponsor Zagazig University
Condition Analgesia, Postoperative
Study Type INTERVENTIONAL
Enrollment 158 participants
Start Date 2024-12-30
Primary Completion 2025-09-30

Eligibility & Interventions

Sex All sexes
Min Age 24 Months
Max Age 12 Years
Study Type INTERVENTIONAL
Interventions
ultrasound guided paravertebral blockUltrasound guided erector spinae plane blockcontrol group C

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 158 participants in total. It began in 2024-12-30 with a primary completion date of 2025-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the study is to compare postoperative analgesia in pediatric patients undergoing inguinal hernia repair by comparing the efficacy of ultrasound guided paravertebral block versus ultrasound guided erector spinae plane block.

Eligibility Criteria

Inclusion Criteria: 1 - Parents acceptance 2\. Age: preschool and school age child (24 months-12 years old). 3\. Sex: both sex (males or females). 4\. Physical status: ASA 1\& II. 5\. Type of operation: elective unilateral inguinal hernia repair Exclusion Criteria: 1- Patient with any contraindications of regional blocks (as coagulopathy or local infection at injection site) 2\. Patients with known history of allergy to the study drugs (bupivacaine and lidocaine). 3\. Advanced hepatic, renal, cardiovascular, neurologic and respiratory diseases.

Contact & Investigator

Central Contact

Dina Sadek Salem, MD

✉ dinamaghraby@yahoo.com

📞 0109933513

Frequently Asked Questions

Who can join the NCT06752252 clinical trial?

This trial is open to participants of all sexes, aged 24 Months or older, up to 12 Years, studying Analgesia, Postoperative. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06752252 currently recruiting?

Yes, NCT06752252 is actively recruiting participants. Contact the research team at dinamaghraby@yahoo.com for enrollment information.

Where is the NCT06752252 trial being conducted?

This trial is being conducted at El Sharkia, Egypt, El Sharkia, Egypt.

Who is sponsoring the NCT06752252 clinical trial?

NCT06752252 is sponsored by Zagazig University. The trial plans to enroll 158 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology